Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Clinical Calcium|December 4, 2004
[Effects of vitamin D on bone quality]Yoshiaki Azuma, Yoshifumi Harada, Seiichi Ishizuka, et al.Clinical Calcium|July 4, 2006
[Vitamin D and cancer]Kei Yamana, Hiroshi Saito, Kazuya Takenouchi, et al.The Journal of Steroid Biochemistry and Molecular Biology|July 1, 2004
Paget's disease-a VDR coactivator disease?Noriyoshi Kurihara, Seiichi Ishizuka, Anne Demulder, et al.The Journal of Steroid Biochemistry and Molecular Biology|July 1, 2004
Synthesis and structure-activity relationships of TEI-9647 derivatives as Vitamin D3 antagonistsKazuya Takenouchi, Ryo Sogawa, Kenji Manabe, et al.Endocrinology|December 25, 2004
(23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's diseaseSeiichi Ishizuka, Noriyoshi Kurihara, Sakamuri V Reddy, et al.Acta Crystallographica. Section D, Biological Crystallography|August 10, 2010
Structural basis of the histidine-mediated vitamin D receptor agonistic and antagonistic mechanisms of (23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactoneShinji Kakuda, Seiichi Ishizuka, Hiroshi Eguchi, et al.The Journal of Biological Chemistry|October 6, 2009
On the mechanism underlying (23S)-25-dehydro-1alpha(OH)-vitamin D3-26,23-lactone antagonism of hVDRwt gene activation and its switch to a superagonistMathew T Mizwicki, Craig M Bula, Paween Mahinthichaichan, et al.Bioorganic & Medicinal Chemistry Letters|July 19, 2008
Structure-activity relationship studies on vitamin D lactam derivatives as vitamin D receptor antagonistKaori Cho, Fumito Uneuchi, Yuko Kato-Nakamura, et al.The Journal of Steroid Biochemistry and Molecular Biology|March 11, 2010
Synthesis of 2beta-substituted-14-epi-previtamin D3 and testing of its genomic activityDaisuke Sawada, Yuya Tsukuda, Hiroshi Saito, et al.The Journal of Steroid Biochemistry and Molecular Biology|July 1, 2004
Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cellsSeiichi Ishizuka, Noriyoshi Kurihara, Daishiro Miura, et al.Pageof 3